Viraday Tablet

Get HIV Treatment has Viraday Tablet available for resellers and stockists. It is a fixed-dose combination antiretroviral at competitive pricing. Pricing details are listed on the product page at Get HIV Treatment. Buyers ordering in volume will find this one of the more consistently stocked antiretroviral combinations in the wholesale market.

Viraday Tablet contains three active ingredients: Efavirenz 600 mg, Emtricitabine 200 mg, and Tenofovir Disoproxil Fumarate 300 mg. All three belong to the nucleoside reverse transcriptase inhibitor and non-nucleoside reverse transcriptase inhibitor drug classes. The product is manufactured by Cipla, India.

It is a once-daily tablet made for ongoing antiretroviral therapy in HIV type 1 infection.

What This Product Treats

Viraday Tablet is used for the management of HIV type 1 infection in adults. The three-compound combination targets the virus through two distinct blocking mechanisms. It covers both the nucleoside and non-nucleoside reverse transcriptase inhibitor pathways.

This dual-class approach makes it a widely stocked antiretroviral across wholesale and institutional supply chains.

Available Strengths and Pack Sizes

The standard strength is Efavirenz 600 mg, Emtricitabine 200 mg, and Tenofovir Disoproxil Fumarate 300 mg in a single tablet. Pack sizes for bulk ordering include strips and bottles depending on quantity. Strip-based packaging is the most common format at the reseller and pharmacy level.

Buyers should confirm current pack configurations directly on the Get HIV Treatment product page.

How It Works

Each of the three active ingredients targets the reverse transcriptase enzyme of HIV. Tenofovir Disoproxil Fumarate is absorbed and converts into its working form through cellular enzymes. Once active, it competes with the natural building blocks the virus uses to copy its DNA.

Emtricitabine works through the same drug class. It blocks the reverse transcriptase enzyme and halts viral DNA production.

Efavirenz works differently. It binds directly to the reverse transcriptase enzyme at a separate site, changing its shape and stopping it from functioning. Together, the three compounds reduce the ability of HIV type 1 to replicate inside the body.

Side Effect

The side effect profile of Viraday Tablet is consistent with the drug classes it contains. Commonly reported effects include dizziness, headache, nausea, diarrhea, and fatigue. Skin rash is also part of the profile.

Efavirenz is known for central nervous system effects including vivid dreams, sleep disturbance, and mood changes. These are most common during the early weeks of use. Buyers stocking this product for resale should be aware that Efavirenz-related central nervous system effects are the most frequently reported across clinical experience with this combination.

Shelf Life and Storage

Viraday Tablet should be stored at controlled room temperature. It is stored below 30 Celsius. Packaging should stay sealed until the point of dispensing. Keep away from humidity, direct sunlight, and heat fluctuation.

Shelf life is typically 24 months from the date of manufacture. Buyers should check the expiry printed on each batch when receiving stock.

Why Buyers Choose This Product

The Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate combination is one of the most widely recognized fixed-dose antiretroviral regimens globally. It is listed in essential medicines frameworks across multiple health systems. Reorder frequency is high.

Stockists who carry this combination alongside other antiretroviral lines report reliable turnover. It is a practical addition to any antiretroviral product catalogue at the reseller level.